Introduction
Trypanosomosis is a disease of vertebrate animals caused by parasitic protozoan of the Genus Trypanosoma. Infection with this parasitic protozoan causes intermittent fever, weight loss, and anemia. The infection is transmitted cyclically by biting insect, especially Glossina species (tse-tse fly). The major species are Trypanosoma brucei brucei, T. vivax, T. evansi, and T. congolense which cause African Animals Trypanosomosis, while human African Trypanosomosis is mainly caused by the remaining sub species of the brucei group, namely, T. brucei gambiense and T. brucei rhodenseinse which causes West African and East African Sleeping Sickness [1, 2] . It is estimated in Africa that large hectares of land approximately 7 million square kilometers of land would have been utilized for grazing if the scourge of trypanosomosis was effectively controlled. It is important to note that only about 30 million cattle are raised in zones were tse-tse was free from a possible population of 140 million [3] . Trypanosomosis has led to the death of about 2 million cattle yearly which has lead to decrease in calving by 20% and milk production by over 20%, which has adversely affected farmers [4] .
Leptadenia hastata is a valuable non-domesticated edible vegetable collected in the wild; typically grown in the tropical areas throughout Africa. The plant belongs to the phylum Tracheophyta and class Magnoliopsida [5, 6] . Its ecological features, together with its particular geographic position, seem to have promoted its diversity, being found in the Northern area, it is considered Arab in origin. However, the fact that it's potential as a vegetable is known to be of specific geographic communities, such as region of Mopti and West Africa [4] . L. hastata is called with different names according to the region. Some of the vernacular names are: Hagalhadjar (Arabic; Chad), Hayla (Kusume; Ethiopia), and Nzongne (Bambara; Mali). In Nigeria, it popularly referred to as Yadiya by Hausa community which are predominantly found in Northern Nigeria and also some parts of Niger [6] [7] [8] .
The major challenge in the treatment of trypanosomosis using standard drugs designed for the treatment of the infection are the reports of resistance to the drugs and relapse during the course of treatment, with series of drug trials it is likely that a better alternative, which would be effective, affordable, and no toxicity, will be discovered [9, 10] . The poor economy and poverty level of farmers in many developing countries where animal rearing is a major source of occupation also forms the basis for the search of a cheaper alternative for the treatment of the disease. The search for alternative drugs for the treatment of the infection has been directed to ethnopharmacology. Medicinal plants, which are known to posses some medicinal properties used traditionally with some active principles, are explored for possible success by scientist conducting various research [11] . L. hastata is used in the traditional medicine and plays an essential role in treating hypertension, catarrh and skin disease in Nigeria [12] , trypanosomosis, sex impotence, wound healing, and against milk drying [13, 14] . The plant is effective against bacteria [15] and also in the treatment of diabetes [16] , anti-fungal activity [15] , and anti-inflammatory effect [17] . In Mali, L. hastata is used effectively in the treatment of onchocercosis [18] . A key factor in the use L. hastata is its safety and is considered non-toxic [14] . Despite the use of the plant traditionally in various infections, this study is geared toward evaluating the potential anti-trypanosomal activity, toxicity, and possible hematological properties through in experimental infection through in vivo approach, in particular the root of the plant since there is paucity of information.
Materials and Methods

Ethical approval
The approval for the research was from the committee of Animal welfare and Central Research from Faculty of Veterinary Medicine in the University of Maiduguri, Nigeria. All the animals were handled according to international guidelines for conducting biomedical research and also considering their welfare [19, 20] .
Identification of the plant and sample collection
An expert Prof. S. S. Sanusi in the field of plant taxonomy from the Department of Biological Science identified the plant with subsequent deposition of the Herbarium specimen in the laboratory. Fresh root of L. hastata was obtained from Dalori, a village in Konduga Local Government close to the state capital Maiduguri. After the collection, the root samples were made clean and kept under the shade to dry and later pulverized into powdery foam called the "plant material."
Plant material extraction
The powdery form of the extract weighed 11.2 kg and a soxhlet apparatus was used to extract the from the plant material using 85% ethanol in distilled water [21] . A rotary evaporator was used to concentrate the extract at reduced pressure.
Phytochemical screening
The secondary plant metabolites, such as carbohydrates, flavonoids, alkaloids, saponin, tannins glycosides, and terpenoids were determined as described by Harborne [22] .
Trypanosomes
T. brucei brucei strain was inoculated in donor rats and was transported to the laboratory where the laboratory animals were stabilized prior to presaging before inoculation in experimental animals. These strains were obtained from Nigerian Institute for Trypanosomosis and Onchocerciasis Research Jos, Nigeria. Parasitic techniques to monitor parasitemia were determined by methods as described by Herbert and Lumsden [23] .
Laboratory animals
Thirty adult Wistar rats comprising of males and females were purchased from a reliable laboratory animal breeder in Maiduguri. The Wistar rats were kept in locally constructed cages which were covered with wire mesh for the purpose of ventilation in the Research Animal Laboratory. Prior to commencement of the research, the laboratory animals were allowed to acclimatize for a period of 2 weeks before the onset of experimental trials, with the provision of adequate feeding with growers mash obtained from vital feed and also water ad libitum.
Experimental drug
Diminazene diaceturate (Iverzene ® ) which contains diminazeneaceturate and Phenazone granules was procured commercially from the market and was reconstituted according to the manufacturer's instruction.
Acute toxicity test
Acute toxicity was calculated as described by Aliu and Nwude [24] .
Inoculation of infection
After successful repeated serial passage of the T. brucei brucei in albino rats in the Veterinary Parasitology Laboratory, parasitemia was established and became patent in the inoculated Wistar rats. After obtaining blood samples from the tail vein, these blood samples from donor rats were kept in a petri-dish were it was diluted with glucose saline. Rats in infected groups were inoculated with about 0.5 ml of blood containing 1.0 × 10 6 T. brucei brucei through intra-peritoneal route, quantified using serial dilution as reported [23] .
Experimental design
Thirty adult Wistar rats were categorized into six groups randomly starting from Group A to Group F with the group having a total five rats in cages, respectively. Intraperitoneal inoculation of infected groups comprising of A, B, C, D, and E was done with the dilution of infected blood from donor rats with glucose saline at a pH of 7.2. Groups A and B were administered 100 and 200 mg of the extract, respectively, as the treatment after inoculation of infection. Rats in Group C were inoculated with the infection but not treated, while those in Group D were not infected and no treatment was administered. Groups E and F were infected and treated with 3.5 and 7.0 mg/kg of diminazene diaceturate (Iverzene), respectively.
Detection of parasitemia
Following inoculation of the respective groups with strains of the trypanosome, all the infected groups became parasitemic 2 days after successful inoculation of infection via the intra-peritoneal route. Blood from the tail vein of Wistar rats were analyzed by wet films with the estimation of the degree of parasitemia by using the rapid matching technique [23] every day for the period of the experiment.
Rapid matching technique for the examination of parasitemia
The number of parasites in each field under the microscope was matched with the standard reference pictures according to Herbert and Lumsden [23] . The count in each field was matched to logarithmic a figure which was converted to numbers to reflect parasitic counts per milliliter.
Determination of packed cell volume
Determination of packed cell volume (PCV) was carried out as described by Coles [25] . Capillary tubes were filled with blood obtained from experimental Wistar rats via the tail vein. The tube ends were sealed using plasticine, while excess blood wiped off using cotton wool. The filled tubes were placed in a slot in a micro hematocrit centrifuge machine (Hawsley, England) with sealed ends outward. The samples were centrifuged at a revolution of 1,200 gm in 5 min. PCV value was read using micro hematocrit reader (Hawsley, England) and then expressed in percentage (%).
Data analysis
Data obtained from the study were presented as mean ± standard deviation (SD) using Analysis of Variance and p < 0.05 was considered as significant [26] . Table 1 presents the phytochemical screening of L. hastata crude root extract which shows the presence of alkaloids, some carbohydrates (e.g., ketoses), cardenolides, cardiac glycosides, flavonoids, saponin, and terpenoids.
Results
Phytochemical screening
Parasitemia
The mean parasite count of Wistar rats experimentally infected with T. brucei brucei with their controls is presented in Figure 1 . In Group A (infected/treated with crude root extract of L. hasata orally at 100 mg/kg) and Group B (infected/treated with crude extract root of L. hastata orally at 200 mg/kg), a uniform prepatent period of 2 days was observed, mean parasitic count of 3.93 ± 2.38 and 2.46 ± 2.20 was observed, respectively, day 2 (P.I). The parasitic counts continued to appreciate significantly (p < 0.05) without abating despite instituting therapy at day 2 (P.I). A parasitemic count of 259.67 ± 3.57 was seen by day 5 post infection When all the Wistar rats died as a result of the infection in Group A. In Group B, the parasitic count continued to appreciate to a significant level (p < 0.05) until 4 days post infection, with the subsequent death of rats in the group.
In Group C of Wistar rats (infected/untreated control), a mean parasitic count of 0.67 ± 0.11 was observed after a prepatent period of 2 days. The parasitic count continued to appreciate at significant level (p < 0.05) until when the rats in the group died 4 days post infection.
In Group D (uninfected/untreated), no parasite was detected throughout the study period.
In Group E (infected/treated with diminazene diaceturate at 3.5 mg/kg) and Group F (infected/treated with diminazene diaceturate at 7.0 mg/kg), a mean parasitic count of 4.60 ± 4.45 and 1.53 ± 1.44 was observed after a pre-patent period of 2 days, this continued to appreciate at a significant level (p < 0.05) to day 3 post infection. Following treatment with diminazene diaceturate, parasitic count began to decline significantly (p < 0.05) until they could no longer be detected in peripheral circulation after 6 days post infection.
Packed cell volume changes
The mean value of PCV in Wistar rats infected with T. brucei brucei with their control is presented in Figure 2 .
Group A is infected and treated with crude root of L. hastata orally at 100 mg/kg, Group B infected and treated with crude extract of L. hastata orally at 200 mg/kg, and Group C is infected/untreated group). The pre-infected values of 48.80 ± 8.93, 47.40 ± 6.84, and 49.20 ± 5.67 were fairly within the same range (p > 0.05) through the entire period of the study period till day 5 for Group A and day 4 for Groups B and C (P.I) when all the infected rats died.
Wistar rats from Group D (uninfected/untreated). Preinfection value of 53.60 ± 4.93 was constant (p > 0.05) during the period of the research throughout the study period.
In Group E (infected and treated with diminazene diaceturate at 3.5 mg/kg), the pre-infection values of 49.80 ± 0.44 remained fairly constant till day 7 post infection or 5 days post treatment, when a decline which was significant (p < 0.05) was seen, while in Group F (infected/treated with diminazene diaceturate at 7.0 mg/kg), the pre-infection value of 48.60 ± 6.22 was constant during the entire study. 
Discussion
Phytochemical anaysis of the Crude root extract of L. hastata showed some pharmacological active substances. These substances include alkaloids, saponins, cardenolides, cardiac glycosides, terpenoids, and flavonoids. However the contradicts the findings of Haruna et al. [4] and Bello et al. [16] were both of the researchers reported alkaloids, steroids, flavanoids, tannins, terpenoids, and anthraquinone in their study. This could probably be result of various method employed in screening of the plants, source of the plant (Location) and could also be dependent on the particular part of the plant employed in the research. The metabolites are known to play various pharmacological roles in the body. Saponins are known to bind cholesterol, block its uptake by the intestine, thus facilitating its excretion as well as the coagulation of red blood cells [27] . Saponins as indicated by previous studies have no toxicity report; especially in blood when administered orally as their biotransformation is fast easily become hydrolyzed [28] . A lot of anti-trypanosomal medicinal plants in Nigeria flora have been proven to possess anti-trypanosomal potentials to combat the disease as in the case of L. hastata leaf has been reported to possess such potentials [29] . Alkaloids are known to possess some very active pharmacological effects, especially in mammals which has lead to its use in most drugs derived from natural environment particularly plants. Studies have shown that flavonoids have pharmacological properties that are effective against bacteria, fungi, and inflammation [30] . This shows its ethnomedical importance in the traditional medicine. However in this study, the extract administered as the treatment in Wistar rats infected with T. brucei brucei did not show any significant effect on the parasitemia as it continue to significantly increase from day 2 post infection to reach the peak by day 4 and by day 5 when all the rats died in groups treated so also the group used as a negative control. This could probably be as a result of the presence or absence of some pharmacological active substances from the photochemical screening of the root and the leaf, as the leaf has been reported to have some anti-trypanosomal activity. In a study by Haruna et al. [4] , various factions of different metabolites revealed that saponins are the most active against trypanosomes proliferation showing it is the most potent anti-typonosomal metabolite of L. hastata leaf. The quantity of saponin was very high in L. hastata leaf. This study did not quantify the various metabolic substances.
Blood vascular system is a target for the most compounds with toxic properties which reflects in both physiological and pathological pathways in mammals [31] . One of the key clinical manifestations of trypanosomosis is anemia [32] . Crude extract of L. hastata-treated groups showed that the PCV remained fairly constant as with the diminazene diaceturate-treated groups and the positive control; this could not for long as all the Wistar rats treated with the extract died by day 6 post infection. Similarly, a significant increase in PCV and hemoglobin count was reported by Abubakar et al. [33] in rats treated with ethanol extract of L. hastata. Since anemia is a cardinal sign of trypanosomosis, this may be an indication that the plant extract could boost blood production and could be used as a possible hematinic agent in the treatment of anemia.
Conclusion
The in vivo studies showed that the root extract of L. hastata had no effect on parasitemia of Wistar rats inoculated with the infection and administered l00 and 200 mg/kg of the extract as the treatment. However, the PCV remained fairly constant during the study, suggesting the possibility of extract being a hematinic agent with no clinical or behavioral changes as a result of toxicity. Further studies should be conducted using higher doses of the extract and with quantitative determination of phytochemical metabolites with multiple treatments to ascertain the effect of the extract and the possible hematinic activity using the same or different animal model.
